423 related articles for article (PubMed ID: 20126449)
1. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
Manicassamy B; Medina RA; Hai R; Tsibane T; Stertz S; Nistal-Villán E; Palese P; Basler CF; García-Sastre A
PLoS Pathog; 2010 Jan; 6(1):e1000745. PubMed ID: 20126449
[TBL] [Abstract][Full Text] [Related]
2. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
[TBL] [Abstract][Full Text] [Related]
3. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
4. Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.
Easterbrook JD; Kash JC; Sheng ZM; Qi L; Gao J; Kilbourne ED; Eichelberger MC; Taubenberger JK
Influenza Other Respir Viruses; 2011 May; 5(3):198-205. PubMed ID: 21477139
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
7. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.
Skountzou I; Koutsonanos DG; Kim JH; Powers R; Satyabhama L; Masseoud F; Weldon WC; Martin Mdel P; Mittler RS; Compans R; Jacob J
J Immunol; 2010 Aug; 185(3):1642-9. PubMed ID: 20585035
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
[TBL] [Abstract][Full Text] [Related]
9. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
10. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.
Guo CY; Tang YG; Qi ZL; Liu Y; Zhao XR; Huo XP; Li Y; Feng Q; Zhao PH; Wang X; Li Y; Wang HF; Hu J; Zhang XJ
Immunobiology; 2015 Aug; 220(8):941-6. PubMed ID: 25708705
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
[TBL] [Abstract][Full Text] [Related]
15. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.
Guo H; Santiago F; Lambert K; Takimoto T; Topham DJ
J Virol; 2011 Jan; 85(1):448-55. PubMed ID: 20980523
[TBL] [Abstract][Full Text] [Related]
17. A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice.
Inn KS; Lee GJ; Quan FS
Immunol Invest; 2014; 43(3):236-54. PubMed ID: 24354853
[TBL] [Abstract][Full Text] [Related]
18. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
[TBL] [Abstract][Full Text] [Related]
19. Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.
Skarlupka AL; Owino SO; Suzuki-Williams LP; Crevar CJ; Carter DM; Ross TM
Hum Vaccin Immunother; 2019; 15(9):2013-2029. PubMed ID: 31448974
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses.
Wan H; Gao J; Xu K; Chen H; Couzens LK; Rivers KH; Easterbrook JD; Yang K; Zhong L; Rajabi M; Ye J; Sultana I; Wan XF; Liu X; Perez DR; Taubenberger JK; Eichelberger MC
J Virol; 2013 Aug; 87(16):9290-300. PubMed ID: 23785204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
